Welcure Drugs, a company in the Pharmaceuticals industry, reported revenue of ₹66 crore and net profit of ₹8.00 crore for the September 2025 quarter.
Welcure Drugs (BSE: WELCURE) closed at ₹0.18 on 20 Nov 2026, down 67.9% over the past year. Its market capitalisation is ₹22 crore.
Incorporated in 1992, Welcure Drugs and Pharmaceuticals Ltd is in the business of pharmaceutical and healthcare.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.